Press release

BioAtla to Participate in the Jefferies London Healthcare Conference

SAN DIEGO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that the Company's management will participate in a fireside chat and scheduled one-on-one investor meetings at the Jefferies London Healthcare Conference, to be held in London, UK November 14–16, 2023.

Format: Fireside chat and one-on-one investor meetings
Date: Wednesday, November 15, 2023
Time: 12:00 p.m. GMT
Location: London, UK
Webcast Link: Click Here

About BioAtla, Inc.
BioAtla is a global clinical-stage biotechnology company with operations in San ...

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner
Trending

More to read